Loading…
Aspire Biopharma Holdings, Inc. is projected to decline to $4.66 by 2027, a 0% move from its current price of $4.67. ASBP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.10 | $4.67 | $5.32 | +0.02% |
| May 30 | $3.88 | $4.67 | $5.62 | +0.04% |
| May 31 | $3.73 | $4.67 | $5.86 | +0.06% |
| Jun 1 | $3.60 | $4.67 | $6.07 | +0.08% |
| Jun 2 | $3.49 | $4.67 | $6.26 | +0.10% |
| Jun 3 | $3.39 | $4.68 | $6.44 | +0.12% |
| Jun 4 | $3.31 | $4.68 | $6.61 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.31 | $4.68 | $6.61 | +0.14% |
| Week 2 | $2.87 | $4.68 | $7.64 | +0.28% |
| Week 3 | $2.57 | $4.69 | $8.54 | +0.42% |
| Week 4 | $2.35 | $4.70 | $9.39 | +0.56% |
| Week 5 | $2.17 | $4.70 | $10.20 | +0.70% |
| Week 6 | $2.02 | $4.71 | $11.00 | +0.84% |
| Week 7 | $1.89 | $4.72 | $11.79 | +0.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company in the Healthcare sector that develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers a sublingual aspirin product that is soluble, PH neutral, and fast acting, addressing cardiology emergencies and pain management.
The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. (ASBP) is currently priced at $4.67 with a market capitalization of $6.05M and a rank of 5222. This places the stock among smaller-cap healthcare opportunities with a near-term price path that shows mixed signals across the forecast horizon.
The 30-day technical picture leans bullish, supported by specific indicator readings and a defined range.
A major floor 96.7% below — a decisive break under it would weaken the trend.
The nearest floor, 96.7% below — buyers have tended to step in here.
The nearest ceiling, 43.0% above — a clean break opens room to run.
A major ceiling 121.8% above — clearing it would confirm fresh momentum.
Key ASBP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ASBP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.35 | Sell | $5.17 | Sell |
| MA 10 | $5.61 | Sell | $4.94 | Sell |
| MA 20 | $3.42 | Buy | $3.95 | Buy |
| MA 50 | $1.81 | Buy | $2.66 | Buy |
| MA 100 | $1.89 | Buy | $3.92 | Buy |
| MA 200 | $6.90 | Sell | $24.39 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.96 | Neutral |
| Stoch RSI (14) | 51.03 | Neutral |
| CCI (20) | 32.43 | Neutral |
| Williams %R (14) | -30.80 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 2424.32 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 69.20 | Neutral |
| TRIX (15) | 10.80 | Buy |
| Awesome (5,34) | 3.13 | Buy |
| Ultimate (7,14,28) | 51.54 | Neutral |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 4.93 | Sell |
| ADX (14) | 44.33 | Buy |
| ATR (14) | 0.43 | Info |
The near-term technical picture is bullish, with RSI14 at 60.00. The 50-day moving average is $1.81 and the 200-day moving average is $6.90. The stock trades within a 30-day range of $1.87 to $11.67.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.155 | $4.67 | $7.35 | 0% | Neutral | |
| $3.36 | $4.66 | $7.01 | 0% | Neutral | |
| $3.08 | $4.54 | $7.26 | -3% | Neutral | |
| $2.82 | $4.38 | $7.34 | -6% | Neutral | |
| $2.39 | $3.88 | $6.77 | -17% | Bearish | |
| $2.57 | $4.36 | $7.87 | -7% | Neutral | |
| $3.19 | $5.65 | $10.50 | +21% | Bullish | |
| $3.61 | $6.67 | $12.74 | +43% | Bullish | |
| $3.21 | $6.17 | $12.08 | +32% | Bullish | |
| $2.67 | $5.32 | $10.65 | +14% | Neutral | |
| $3.66 | $8.13 | $17.88 | +74% | Bullish | |
| $5.22 | $11.60 | $26.68 | +148% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.155 | $4.67 | $5.59 | +0.00% |
| June 2026 | $4.06 | $4.86 | $6.04 | +4.14% |
| July 2026 | $3.90 | $4.76 | $6.06 | -2.22% |
| August 2026 | $4.04 | $4.99 | $6.48 | +4.90% |
| September 2026 | $4.32 | $5.40 | $7.12 | +8.22% |
| October 2026 | $4.25 | $5.36 | $7.18 | -0.63% |
| November 2026 | $4.07 | $5.19 | $7.03 | -3.31% |
| December 2026 | $4.17 | $5.37 | $7.35 | +3.46% |
Click any year to see its month-by-month ASBP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ASBP price prediction for 2026 points to an average of $4.67 (low $0.155, high $7.35) — a potential gain of 0% on today's $4.67. A consolidation phase looks the most probable path here.
In 2027, ASBP is projected to trade between $3.36 and $7.01, averaging $4.66 — a potential decline of 0% from today's $4.67. That is 0% versus the projected 2026 average. Price action looks broadly range-bound.
Aspire Biopharma Holdings, Inc.'s 2028 outlook centres on $4.54, within a $3.08 to $7.26 range. That is -3% versus the projected 2027 average. That marks a -3% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ASBP could reach as high as $7.34, with a base case around $4.38 and support toward $2.82 — roughly -6% from $4.67. Price action looks broadly range-bound.
Expect ASBP to range from $2.39 to $6.77 through 2030. The $3.88 average target implies a -17% move from current prices. That is -11% versus the projected 2029 average. Expect choppier, lower action through this leg of the cycle.
The ASBP price prediction for 2031 points to an average of $4.36 (low $2.57, high $7.87) — a potential decline of -7% on today's $4.67. Price action looks broadly range-bound.
In 2032, ASBP is projected to trade between $3.19 and $10.50, averaging $5.65 — a potential gain of +21% from today's $4.67. That is up +29% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Aspire Biopharma Holdings, Inc.'s 2033 outlook centres on $6.67, within a $3.61 to $12.74 range. That is up +18% on the projected 2032 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2034, ASBP could reach as high as $12.08, with a base case around $6.17 and support toward $3.21 — roughly +32% from $4.67. Buyers look set to stay in control over this stretch.
Expect ASBP to range from $2.67 to $10.65 through 2035. The $5.32 average target implies a +14% move from current prices. That is -14% versus the projected 2034 average. Price action looks broadly range-bound.
The ASBP price prediction for 2040 points to an average of $8.13 (low $3.66, high $17.88) — a potential gain of +74% on today's $4.67. Buyers look set to stay in control over this stretch.
In 2050, ASBP is projected to trade between $5.22 and $26.68, averaging $11.60 — a potential gain of +148% from today's $4.67. That is up +43% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ASBP today (≈ 214.132762 ASBP) could be worth
$2,484.23
+$1,484.23 (+148%) by 2050 · US Dollar
Based on the average projected ASBP price of $11.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ASBPwould be worth at today's price.
$1,000 invested in ASBP on May 27, 2025 (≈ 105.042012 ASBP) would be worth
$490.55
-$509.45 (-50.9%) today · 0.49× · US Dollar
Based on a ASBP entry price of $9.52 vs. today's $4.67.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.03 | $774.46 | -22.6% |
| 1 month ago | $0.245 | $19,061.22 | +1806.1% |
| 3 months ago | $1.45 | $3,220.69 | +222.1% |
| 6 months ago | $4.24 | $1,101.42 | +10.1% |
| 1 year ago | $9.52 | $490.55 | -50.9% |
| All time (4.1y) ago | $399.6 | $11.69 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ASBP forecast.
Our base-case forecast reaches $9.30 around 2050.
Implied market cap at $9.30: $12.05M
The multi-year forecast shows a mixed path. In 2026 the average price is $4.67 with a 0% ROI and a Neutral sentiment. By 2030 the average price is $3.88 with a -16.9% ROI and a Bearish sentiment.
A recovery appears from 2032 onward, with 2032 average $5.65 (20.9% ROI) and 2033 average $6.67 (42.8% ROI), followed by 2034 average $6.17 (32.1% ROI). The forecast strengthens into 2040 with an average of $8.13 (69.1% ROI) and a 2050 average of $11.60 (148.4% ROI), both labeled Bullish. These figures illustrate potential upside over the long term, alongside notable downside risk around 2030.
Tap a question to reveal the answer.
2030 forecast: min $2.39, avg $3.88, max $6.77 with ROI -16.9% and sentiment Bearish.
Near term is Neutral through 2026-2029, with a Bearish phase around 2030, followed by bullish prospects from 2032 onward, including 2032 avg $5.65 (20.9% ROI) and 2050 avg $11.60 (148.4% ROI).
Yes. The forecast shows several years with max values above $10, including 2033 max $12.74, 2034 max $12.08, 2040 max $17.88, and 2050 max $26.68.
Current price is $4.67 and market capitalization is $6.05M.
Market sentiment is BULLISH with RSI14 at 60. SMA50 is $1.81 and SMA200 is $6.90. The 30-day range is $1.87 to $11.67, with support at $0.155 and resistance at $6.68.
Aspire Biopharma Holdings, Inc. Community Discussion
0Share your Aspire Biopharma Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.